Several peripheral and central mechanisms are believed to be involved, including altered gut hormone secretion, decrease in energy expenditure following weight loss, and psychological processes associated with the food reward system
These symptoms can indicate conditions like gastroparesis (severe delayed gastric emptying beyond what the medication causes), bowel obstruction, or other digestive pathology that requires medical evaluation
Daily oral L-carnosine (500 mg, p.o., daily for 3 months) significantly ameliorated the pathophysiological triad of inflammation, oxidative stress, and apoptosis in patients receiving FOLFOX-6 regimen (OXA + 5FU + leucovorin), for instance, decreasing the molondialdehyde (MDA) level (51.8%), nuclear factor-B (NF-B) (27%), and TNF- (36.6%), while increasing Nrf-2 (38.7%) (Yehia et al., 2019)
Because users vary in how they describe their symptoms, the effort required to map individual social media posts to language in the Medical Dictionary for Regulatory Activities (MedDRA), which clinicians use to describe symptoms, limited the amount of data this approach could handle
The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice